| Literature DB >> 30479494 |
Hyemin Oh1,2, Sejeong Kim1,2, Soomin Lee1,2, Heeyoung Lee1,2, Jimyeong Ha1,2, Jeeyeon Lee1,2, Yukyung Choi1,2, Kyoung-Hee Choi3, Yohan Yoon1,2.
Abstract
This study investigated the prevalence of Listeria monocytogenes in slaughterhouses, and determined serovars and genotypes, and antibiotic resistance of the isolates obtained from slaughterhouses and humans in Korea. Two hundred ninety samples were collected from feces (n=136), carcasses [n=140 (cattle: n=61, swine: n=79)], and washing water (n=14) in nine slaughterhouses. Eleven human isolates were obtained from hospitals and the Korea Center for Disease Control and Prevention. Listeria monocytogenes was enriched and identified, using polymerase chain reaction (PCR) and 16S rRNA sequencing. Serovars and presence of virulence genes were determined, and genetic correlations among the isolates were evaluated by the restriction digest patterns of AscI. Antibiotic resistance of L. monocytogenes isolates were examined against 12 different antibiotics. Of 290 slaughterhouse samples, 15 (5.17%) carcass samples were L. monocytogenes positive. Most L. monocytogenes isolates possessed all the virulence genes, while polymorphisms in the actA gene were found between carcass and human isolates. Serovars 1/2a (33.3%) and 1/2b (46.7%) were the most frequent in carcass isolates. Genetic correlations among the isolates from carcass and clinical isolates were grouped within serotypes, but there were low geographical correlations. Most L. monocytogenes isolates were antibiotic resistant, and some strains showed resistance to more than four antibiotics. These results indicate that L. monocytogenes are isolated from carcass and human in Korea, and they showed high risk serotypes and antibiotic resistance. Therefore, intensive attentions are necessary to be aware for the risk of L. monocytogenes in Korea.Entities:
Keywords: Listeria monocytogenes; antibiotic; epidemiological analysis; molecular typing; slaughterhouse
Year: 2018 PMID: 30479494 PMCID: PMC6238023 DOI: 10.5851/kosfa.2018.e5
Source DB: PubMed Journal: Korean J Food Sci Anim Resour ISSN: 1225-8563 Impact factor: 2.622
Primers used for PCR amplification of virulence genes from Listeria monocytogenes isolates
| Primer | Size (bp) | Sequence (5´ to 3´) | Reference |
|---|---|---|---|
| 255 | F :
CCTAGCAGGTCTAACCGCAC | ||
| 146 | F :
AAAGCACGATTTCATGGGAG | ||
| 174 | F :
GCATCTGCATTCAATAAAGA | ||
| 268(385) | F :
GACGAAAATCCCGAAGTGAA | ||
| 261 | F :
GGGAAATTTGACACAGCGTT |
PCR, Polymerase chain reaction.
Prevalence of Listeria monocytogenes in the slaughterhouse
| Slaughterhouse | Sample | Total (%) | ||
|---|---|---|---|---|
| Feces | Carcass (%) | Environment | ||
| Central 1 | 0/18 | 5/18(27.78) | 0/1 | 5/37(13.51) |
| Central 2 | 0/18 | 1/18(5.56) | 0/2 | 1/38(2.63) |
| Central 3 | 0/18 | 2/18(11.11) | 0/2 | 2/38(5.26) |
| Central 4 | 0/3 | 0/6 | 0 | 0/9 |
| South west 1 | 0/18 | 4/18(22.22) | 0/2 | 4/38(10.53) |
| South west 2 | 0/18 | 1/19(5.26) | 0/2 | 1/39(2.56) |
| South east 1 | 0/15 | 2/15(13.33) | 0/2 | 2/32(6.25) |
| South east 2 | 0/19 | 0/19 | 0/2 | 0/40 |
| South east 3 | 0/9 | 0/9 | 0/1 | 0/19 |
| Total | 0/136 | 15/140(10.71) | 0/14 | 15/290(5.17) |
Serotypes and information of Listeria monocytogenes isolates from humans
| Strains | Sources | Serotype |
|---|---|---|
| SMFM-CI-1 | Male, 18 year-old | 4b |
| SMFM-CI-2 | Human, blood, 1/2a | 1/2a |
| SMFM-CI-3 | Female, blood, 82 year-old | 1/2b |
| SMFM-CI-4 | Female, blood, 72 year-old | 1/2b |
| SMFM-CI-5 | Male, blood, 67 year-old | 3b |
| SMFM-CI-6 | Male, blood, 71 year-old | 1/2b |
| SMFM-CI-7 | Male, blood, 73 year-old | 1/2a |
| SMFM-CI-8 | Male, stomach cancer, 66 year-old | 1/2c |
| SMFM-CI-9 | Female, bacterial meningitis, 61 year-old | 4d |
| SMFM-CI-10 | Male, bacterial meningitis, 78 year-old | 4b |
| SMFM-CI-11 | Female, hepatic abscess, 81 year-old | 4b |
Serotypes and information of Listeria monocytogenes isolates from carcasses
| Strains | Sampling location[ | Animal | Serotype |
|---|---|---|---|
| SMFM-SI-1 | A | Swine | 1/2b |
| SMFM-SI-2 | A | Swine | 1/2b |
| SMFM-SI-3 | A | Swine | 1/2b |
| SMFM-SI-4 | A | Swine | 1/2b |
| SMFM-SI-5 | A | Swine | 1/2b |
| SMFM-SI-6 | E | Cattle | 1/2a |
| SMFM-SI-7 | E | Cattle | 1/2c |
| SMFM-SI-8 | E | Cattle | 1/2c |
| SMFM-SI-9 | E | Cattle | 1/2c |
| SMFM-SI-10 | B | Cattle | 1/2a |
| SMFM-SI-11 | C | Swine | 1/2a |
| SMFM-SI-12 | C | Swine | 1/2a |
| SMFM-SI-13 | D | Swine | 1/2b |
| SMFM-SI-14 | D | Swine | 1/2b |
| SMFM-SI-15 | F | Swine | 1/2a |
1) A, slaughterhouse-1 in central area; B, slaughterhouse-2 in central area; C, slaughterhouse-3 in central area; D, slaughterhouse-1 in south west area; E, slaughterhouse-1 in south west area; F, slaughterhouse-2 in south west area.
Fig. 1PCR amplification of InlB from Listeria monocytogenes isolates (SI) obtained from carcasses.
PCR amplification showed that L. monocytogenes isolate SI-15 has no inlB, which plays a role in invasion.
Fig. 2PCR amplification of actA from Listeria monocytogenes isolates obtained from humans (A; CI) and carcasses (B; SI).
ActA gene showed generally different size of base pair between slaughterhouse and human isolates. 90.9% of human isolates had 268 bp size of actA, and 86.7% of slaughterhouse isolates had 385 bp.
Fig. 3PFGE patterns observed for Listeria monocytogenes isolates from carcasses and humans.
Dendrogram (UPGMA clustering based on the Dice correlation coefficient) of L. monocytogenes AscI PFGE patterns for 26 clinical and slaughterhouse isolates. Region 1: central area, Region 2: south west area, Region, 3: south east area. PFGE, pulsed-field gel electrophoresis; UPGMA, unweighted pair group method with arithmetic mean.
Antibiotic sensitivity of Listeria monocytogenes strains isolated from slaughterhouses (n=15)
| Antibiotics | Strains isolated from slaughterhouse | Sensitivity of the isolates (n, %) 1) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMFM-SI-1 | SMFM-SI-2 | SMFM-SI-3 | SMFM-SI-4 | SMFM-SI-5 | SMFM-SI-6 | SMFM-SI-7 | SMFM-SI-8 | SMFM-SI-9 | SMFM-SI-10 | SMFM-SI-11 | SMFM-SI-12 | SMFM-SI-13 | SMFM-SI-14 | SMFM-SI-15 | Susceptible | Intermediate | Resistant | |
| Gentamycin | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Bacitracin | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Penicillin G | R | R | R | R | R | R | R | S | R | R | R | R | R | R | R | 1 | 14 | |
| Tetracycline | S | S | S | S | S | S | S | S | R | S | S | S | R | R | S | 12 | 3 | |
| Spectinomycin | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Kanamycin | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Erythro-mycin | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Tigecycline | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Ampicillin | S | I | I | S | S | I | S | S | S | R | S | R | R | R | I | 7 | 4 | 4 |
| Strepto-mycin | I | R | R | R | I | R | R | I | I | I | R | R | R | R | I | 6 | 9 | |
| Chloram-phenicol | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Rifampicin | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 15 | ||
| Susceptible | 10 | 9 | 9 | 10 | 10 | 9 | 10 | 11 | 9 | 9 | 11 | 9 | 8 | 8 | 9 | |||
| Intermediate | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | |||
| Resistant | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 1 | 3 | 4 | 4 | 1 | |||
According to CLSI guidelines using the breakpoints of Staphylococcus species resistance because no resistance criteria exist for Listeria susceptibility testing in the CLSI guidelines (Byrne et al., 2016).
Antibiotic sensitivity of Listeria monocytogenes strains obtained from human (n=11)
| Antibiotics | Strains obtained from human | Sensitivity of the
isolates (n, %)[ | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMFM-CI-1 | SMFM-CI-2 | SMFM-CI-3 | SMFM-CI-4 | SMFM-CI-5 | SMFM-CI-6 | SMFM-CI-7 | SMFM-CI-8 | SMFM-CI-9 | SMFM-CI-10 | SMFM-CI-11 | Susceptible | Intermediate | Resistant | ||
| Gentamycin | S | S | S | S | S | S | S | S | S | S | S | 11 | |||
| Bacitracin | S | R | S | R | S | S | R | S | S | S | S | 8 | 3 | ||
| Penicillin G | R | R | R | R | R | R | R | R | R | R | R | 11 | |||
| Tetracycline | S | S | R | S | R | R | S | S | S | S | S | 8 | 3 | ||
| Spectinomycin | S | S | S | S | S | S | S | S | S | S | S | 11 | |||
| Kanamycin | S | S | S | S | S | S | S | S | S | S | S | 11 | |||
| Erythromycin | S | I | S | R | S | S | R | S | S | S | S | 8 | 1 | 2 | |
| Tigecycline | S | S | S | S | S | S | S | S | S | S | S | 11 | |||
| Ampicillin | S | R | S | R | S | S | R | S | S | S | S | 8 | 3 | ||
| Streptomycin | I | R | R | R | R | R | R | S | R | I | I | 1 | 3 | 7 | |
| Chloramphenicol | S | S | S | S | S | S | S | S | S | S | S | 11 | |||
| Rifampicin | S | R | S | R | S | S | R | S | S | S | S | 8 | 3 | ||
| Susceptible | 10 | 6 | 9 | 6 | 9 | 9 | 6 | 11 | 10 | 10 | 10 | ||||
| Intermediate | 1 | 1 | 1 | 1 | |||||||||||
| Resistant | 1 | 5 | 3 | 6 | 3 | 3 | 6 | 1 | 2 | 1 | 1 | ||||
1) According to CLSI guidelines using the breakpoints of Staphylococcus species resistance because no resistance criteria exist for Listeria susceptibility testing in the CLSI guidelines (Byrne et al., 2016).